Medicare Enrolled
Dr. Richard Orlowski, MD
Hematology & Oncology · Hickory, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Orlowski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Orlowski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Orlowski
Dr. Richard Orlowski is a hematology & oncology specialist in Hickory, NC, with 21 years of NPI registration. Based on federal Medicare data, Dr. Orlowski performed 102,144 Medicare services across 4,139 unique beneficiaries.
Between the years covered by Open Payments, Dr. Orlowski received a total of $24,430 from 110 pharmaceutical and/or device companies across 1406 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Orlowski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 3% volume in NC
$24,430 industry payments
Medicare Practice Summary
Medicare Utilization ↗102,144
Medicare services
Top 3% in NC for hematology & oncology
4,139
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,864 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
27,000 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 19,800 | $43 | $92 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
14,100 | $0 | $14 |
| Denosumab injection (Prolia/Xgeva) | 9,600 | $18 | $39 |
| Lanreotide injection, 1 mg A 1 mg injection of lanreotide medication administered into the body. |
7,560 | $40 | $113 |
| Iron infusion (Monoferric) | 4,500 | $16 | $36 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
3,111 | $8 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,400 | $0 | $3 |
| Injection, fulvestrant, 25 mg | 1,590 | $8 | $138 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,430 | $6 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,170 | $91 | $167 |
| Anti-nausea injection (ondansetron/Zofran) | 796 | $0 | $22 |
| Injection, leucovorin calcium, per 50 mg | 782 | $3 | $13 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
656 | $10 | $38 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
624 | $135 | $243 |
| Anti-nausea injection (Aloxi/palonosetron) | 570 | $1 | $43 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
504 | $2 | $10 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
458 | $96 | $336 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
362 | $22 | $86 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
333 | $13 | $33 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
288 | $2 | $235 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
250 | $16 | $40 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
250 | $12 | $59 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
238 | $54 | $114 |
| Thyroxine (T4) level test A blood test that measures the total amount of thyroxine, a thyroid hormone, in your body. |
235 | $7 | $14 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 229 | $20 | $50 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 211 | $3 | $196 |
| Adrenocorticotropic hormone (ACTH) level test A blood test that measures the amount of adrenocorticotropic hormone in your body. |
202 | $38 | $91 |
| Total cortisol level test A blood test that measures the total amount of cortisol hormone in your body. Cortisol is a hormone produced by the adrenal glands. |
202 | $16 | $39 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
199 | $0 | $0 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
191 | $49 | $185 |
| Injection, potassium chloride, per 2 meq | 185 | $0 | $3 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
159 | $61 | $115 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
153 | $21 | $75 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
151 | $48 | $184 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 136 | $341 | $853 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
135 | $18 | $45 |
| PSA test (prostate cancer screening) | 131 | $18 | $44 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
125 | $0 | $14 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
113 | $29 | $70 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
106 | $1 | $9 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
87 | $17 | $146 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
83 | $8 | $10 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
77 | $15 | $48 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
75 | $24 | $122 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
72 | $120 | $271 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
72 | $2 | $15 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
67 | $48 | $65 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
57 | $175 | $610 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
42 | $57 | $145 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
41 | $3 | $14 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
38 | $16 | $50 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
32 | $10 | $39 |
| New patient office visit, complex (60-74 min) | 31 | $161 | $345 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 28 | $20 | $58 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
22 | $10 | $52 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
20 | $45 | $132 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
19 | $157 | $343 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
18 | $26 | $89 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $135 | $315 |
| Virtual check-in for established patient A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in. |
12 | $10 | $34 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
32.2% high complexity
60.3% medium
7.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,430
Total received (2018-2024)
Avg $3,490/year across 7 years
Top 17% in NC for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
110
Companies
1,406
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,819 (89.3%)
Other
Charitable contributions, space rental, and other categories
$1,972 (8.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$639 (2.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,519
2023
$3,593
2022
$3,788
2021
$4,511
2020
$3,269
2019
$2,784
2018
$2,965
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$319
PFIZER INC.
$257
AstraZeneca Pharmaceuticals LP
$232
Merck Sharp & Dohme LLC
$223
Janssen Biotech, Inc.
$188
E.R. Squibb & Sons, L.L.C.
$169
Incyte Corporation
$143
Eisai Inc.
$134
Takeda Pharmaceuticals U.S.A., Inc.
$132
Genentech USA, Inc.
$128
Astellas Pharma US Inc
$114
Exelixis Inc.
$113
PUMA BIOTECHNOLOGY, INC.
$112
Daiichi Sankyo Inc.
$99
ARRAY BIOPHARMA INC
$83
GlaxoSmithKline, LLC.
$82
Bayer Healthcare Pharmaceuticals Inc.
$75
Genmab U.S., Inc.
$75
Aveo Pharmaceuticals, Inc.
$70
Karyopharm Therapeutics Inc.
$65
GENZYME CORPORATION
$63
Alexion Pharmaceuticals, Inc.
$55
Lilly USA, LLC
$51
SERVIER PHARMACEUTICALS LLC
$49
Gilead Sciences, Inc.
$41
TAIHO ONCOLOGY, INC.
$40
Acrotech Biopharma Inc.
$38
Ipsen Biopharmaceuticals, Inc
$36
Avyxa Pharma, LLC
$34
Mirati Therapeutics, Inc.
$33
Fresenius Kabi USA, LLC
$26
Coherus Biosciences Inc.
$23
Celgene Corporation
$22
Adaptive Biotechnologies Corporation
$20
Myriad Genetic Laboratories, Inc.
$20
Celltrion USA Inc.
$19
Azurity Pharmaceuticals, Inc.
$18
JAZZ PHARMACEUTICALS INC.
$17
SOBI, INC
$16
SpringWorks Therapeutics, Inc.
$15
ADC Therapeutics America, Inc.
$15
EMD Serono, Inc.
$15
BeiGene USA, Inc.
$14
Spectrum Pharmaceuticals Inc.
$13
ABBVIE INC.
$13
Top 3 companies account for 23.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$3,148
Genentech USA, Inc.
$1,524
AstraZeneca Pharmaceuticals LP
$1,378
E.R. Squibb & Sons, L.L.C.
$1,216
PFIZER INC.
$1,154
Janssen Biotech, Inc.
$963
Incyte Corporation
$851
Daiichi Sankyo Inc.
$779
Amgen Inc.
$764
GENZYME CORPORATION
$738
Exelixis Inc.
$706
Merck Sharp & Dohme Corporation
$618
Eisai Inc.
$542
Celgene Corporation
$539
Merck Sharp & Dohme LLC
$508
Takeda Pharmaceuticals U.S.A., Inc.
$474
Alexion Pharmaceuticals, Inc.
$458
Seagen Inc.
$390
GlaxoSmithKline, LLC.
$316
Lilly USA, LLC
$300
Bayer HealthCare Pharmaceuticals Inc.
$299
Pharmacyclics LLC, An AbbVie Company
$253
Astellas Pharma US Inc
$252
EMD Serono, Inc.
$240
Boehringer Ingelheim Pharmaceuticals, Inc.
$234
Karyopharm Therapeutics Inc.
$232
ARRAY BIOPHARMA INC
$217
PUMA BIOTECHNOLOGY, INC.
$205
EISAI INC.
$196
BeiGene USA, Inc.
$187
Gilead Sciences, Inc.
$181
Novocure Inc.
$172
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Bayer Healthcare Pharmaceuticals Inc.
$161
Regeneron Healthcare Solutions, Inc.
$146
Taiho Oncology, Inc.
$133
JAZZ PHARMACEUTICALS INC.
$132
Ipsen Biopharmaceuticals, Inc
$132
Genmab U.S., Inc.
$122
Clovis Oncology, Inc.
$118
AbbVie, Inc.
$113
SANOFI-AVENTIS U.S. LLC
$111
AbbVie Inc.
$106
Seattle Genetics, Inc.
$101
SERVIER PHARMACEUTICALS LLC
$98
Dova Pharmaceuticals
$98
Coherus Biosciences Inc.
$90
Mirati Therapeutics, Inc.
$89
TerSera Therapeutics LLC
$88
Aveo Pharmaceuticals, Inc.
$85
Epizyme, Inc.,
$85
Puma Biotechnology, Inc.
$82
Myriad Genetic Laboratories, Inc.
$81
TESARO, Inc.
$81
Octapharma USA, Inc.
$77
Foundation Medicine, Inc.
$70
Mylan Institutional Inc.
$61
Acrotech Biopharma LLC
$60
Agios Pharmaceuticals, Inc.
$55
Verastem, Inc.
$55
Acrotech Biopharma Inc.
$54
EUSA Pharma (US) LLC
$54
Heron Therapeutics, Inc.
$53
Sun Pharmaceutical Industries Inc.
$52
Deciphera Pharmaceuticals Inc.
$52
Sobi, Inc
$51
ABBVIE INC.
$51
Pharmacyclics LLC, an AbbVie Company
$48
G1 Therapeutics, Inc.
$46
AMAG Pharmaceuticals, Inc.
$46
TG Therapeutics, Inc.
$46
Secura Bio, Inc.
$45
Inari Medical, Inc.
$45
Helsinn Therapeutics (U.S.), Inc.
$43
ADC Therapeutics America, Inc.
$41
PharmaEssentia USA Corporation
$40
TAIHO ONCOLOGY, INC.
$40
Teva Pharmaceuticals USA, Inc.
$40
Janssen Scientific Affairs, LLC
$38
Servier Pharmaceuticals LLC
$36
Jazz Pharmaceuticals Inc.
$36
Kyowa Kirin, Inc.
$35
Adaptive Biotechnologies Corporation
$34
Avyxa Pharma, LLC
$34
AVEO Pharmaceuticals, Inc.
$31
Janssen Pharmaceuticals, Inc
$31
Spectrum Pharmaceuticals Inc.
$29
Global Blood Therapeutics, Inc.
$28
Rigel Pharmaceuticals, Inc.
$27
Lexicon Pharmaceuticals, Inc.
$27
Fresenius Kabi USA, LLC
$26
Sysmex Inostics Inc
$24
MorphoSys, US Inc.
$24
Organon LLC
$23
Kite Pharma, Inc.
$23
Pharmacosmos Therapeutics Inc.
$22
Sirtex Medical Inc
$20
Stemline Therapeutics Inc.
$19
Celltrion USA Inc.
$19
Array BioPharma Inc.
$18
Amneal Pharmaceuticals LLC
$18
Azurity Pharmaceuticals, Inc.
$18
Acceleron Pharma, Inc.
$17
Medtronic, Inc.
$17
SOBI, INC
$16
SpringWorks Therapeutics, Inc.
$15
Aurobindo Pharma USA, Inc.
$14
Nestle HealthCare Nutrition Inc.
$12
TG THERAPEUTICS, INC.
$12
INSYS Therapeutics Inc
$12
Top 3 companies account for 24.8% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CAMZYOS · CARVYKTI · CERDELGA · CEREZYME · CHANTIX · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Cinvanti · Copiktra · DARZALEX · DOPTELET · Docivyx · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FARESTON · FARYDAK · FERAHEME · FLOWTRIEVER CATHETER · FOLOTYN · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · Farydak · Fulphila · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · Jakafi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MYLOTARG · MYRISK · Monoferric · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORENCIA · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · Ogivri · Oncology · Onivyde · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PROSTATE CANCER - DISEASE · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETACRIT · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rubraca · S · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYNAGIS · SYNDROS · Stimufend · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Tivdak · Trodelvy · Truxima · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VEGZELMA · VENCLEXTA · VERZENIO · VIVIMUSTA · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · YONSA · ZEJULA · ZENPEP · ZEPZELCA · ZOLADEX · ZYTIGA · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
7
Per 100K population
4.3
County median income
$64,544
Nearest hospital
CATAWBA VALLEY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Orlowski is a mixed practice specialist, with above-average Medicare volume (top 3% in NC), with low-engagement industry engagement in the top 17% of NC peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Orlowski experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Orlowski performed 27,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Orlowski receive payments from pharmaceutical companies?
Yes. Dr. Orlowski received a total of $24,430 from 110 companies across 1,406 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Orlowski's costs compare to other hematology & oncology specialists in Hickory?
Dr. Orlowski's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Orlowski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Hickory
Browse hematology & oncology specialists in Hickory ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NC
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NC
Which NC hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology